G P Bates
Overview
Explore the profile of G P Bates including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
6647
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Orth M, Cooper J, Bates G, Schapira A
J Neurochem
. 2003 Sep;
87(1):1-6.
PMID: 12969246
Huntington's disease (HD) is an autosomal dominant disorder caused by an expansion in the number of glutamine repeats in the N-terminal region of the huntingtin protein. Nuclear and cytoplasmic aggregates...
2.
Fluid losses and hydration status of industrial workers under thermal stress working extended shifts
Brake D, Bates G
Occup Environ Med
. 2003 Jan;
60(2):90-6.
PMID: 12554834
Aims: To assess whether workers under significant thermal stress necessarily dehydrated during their exposure and whether "involuntary dehydration" was inevitable, as supported by ISO 9866 and other authorities. Other objectives...
3.
Smith D, Portier R, Woodman B, Hockly E, Mahal A, Klunk W, et al.
Neurobiol Dis
. 2001 Dec;
8(6):1017-26.
PMID: 11741397
Huntington's disease (HD) is a late onset neurodegenerative disorder caused by a CAG/polyglutamine (polyQ) repeat expansion. PolyQ aggregates can be detected in the nuclei and processes of neurons in HD...
4.
Brake D, Bates G
Occup Med (Lond)
. 2001 Nov;
51(7):456-63.
PMID: 11719616
A field investigation to examine the fatigue levels in industrial workers working extended (10, 12 and 12.5 h) shifts under significant levels of thermal stress was conducted on 45 male...
5.
Sathasivam K, Woodman B, Mahal A, BERTAUX F, Wanker E, Shima D, et al.
Hum Mol Genet
. 2001 Nov;
10(21):2425-35.
PMID: 11689489
Huntington's disease (HD) is a progressive neurological disorder caused by a CAG/polyglutamine repeat expansion. We have previously generated the R6/2 mouse model that expresses exon 1 of the human HD...
6.
7.
Lievens J, Woodman B, Mahal A, Samuel D, Kerkerian-Le Goff L, Bates G
Neurobiol Dis
. 2001 Oct;
8(5):807-21.
PMID: 11592850
Huntington's disease (HD) is a late-onset neurodegenerative disease for which the mutation is CAG/polyglutamine repeat expansion. The R6 mouse lines expressing the HD mutation develop a movement disorder that is...
8.
Waelter S, Scherzinger E, Hasenbank R, Nordhoff E, Lurz R, Goehler H, et al.
Hum Mol Genet
. 2001 Sep;
10(17):1807-17.
PMID: 11532990
The huntingtin interacting protein (HIP1) is enriched in membrane-containing cell fractions and has been implicated in vesicle trafficking. It is a multidomain protein containing an N-terminal ENTH domain, a central...
9.
Hansson O, Castilho R, Korhonen L, Lindholm D, Bates G, Brundin P
J Neurochem
. 2001 Aug;
78(4):694-703.
PMID: 11520890
Transgenic Huntington's disease (HD) mice, expressing exon 1 of the HD gene with an expanded CAG repeat, are totally resistant to striatal lesion induced by excessive NMDA receptor activation. We...
10.
Kusakabe M, Mangiarini L, Laywell E, Bates G, Yoshiki A, Hiraiwa N, et al.
J Comp Neurol
. 2001 Feb;
430(4):485-500.
PMID: 11169482
A transgenic mouse containing the first exon of the human Huntington's disease (HD) gene has revealed a variety of behavioral and pathophysiological anomalies reminiscent of certain aspects of human Huntington's...